CDC25B and hepatocellular carcinoma: Combined with the existing studies, we can determine that CDC25B promotes the proliferation of HCC cells by participating in the MAPK signaling pathway and mediates DNA damage and repair through the P53 signaling pathway; in addition, the overexpression of CDC25B affects the alteration of the TME and the upregulation of immune checkpoints.